{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T22:12:03Z","timestamp":1747174323023,"version":"3.40.5"},"reference-count":13,"publisher":"Hogrefe Publishing Group","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Praxis"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:p> Zusammenfassung. Nicht-steroidale Antirheumatika sollen gem\u00e4ss der nephrologischen Empfehlung im Rahmen der Choosing-Wisely-Kampagne bei Personen mit kardialen sowie renalen Erkrankungen vermieden werden. Diese Studie liefert einerseits quantitative Daten zum NSAR-Gebrauch in der Schweiz, andererseits Hinweise, wie sich nach Einf\u00fchrung der Empfehlung die Abrechnungsh\u00e4ufigkeit von NSAR bei Risikopersonen ver\u00e4ndert hat. Methode: Sekund\u00e4ranalyse von Abrechnungsdaten der obligatorischen Krankenpflegeversicherung. Die H\u00e4ufigkeit des NSAR-Bezugs wurde stratifiziert nach Soziodemografie sowie Komorbidit\u00e4ten \u00abKardiologie\u00bb und \u00abNiereninsuffizienz\u00bb. Ergebnisse: Es konnte erstmalig gezeigt werden, dass 33,6% der gesamten Studienpopulation, 42,1% der kardialen Risikopopulation und 18% der renalen Risikopopulation NSAR konsumieren. Es fand sich eine leichte Tendenz zur Absenkung der Abrechnungsh\u00e4ufigkeit nach Einf\u00fchrung der Empfehlung. Diskussion: Es braucht priorit\u00e4r weitere Studien, um den Einsatz der potenziell gesundheitssch\u00e4digenden NSAR in anderen Risikogruppen zu quantifizieren, und anhand der weiteren Studienergebnisse sollte \u00fcberlegt werden, wie die Choosing-Wisely-Empfehlung vermehrt umgesetzt werden kann, vor allem auch in der Allgemeinbev\u00f6lkerung. <\/jats:p>","DOI":"10.1024\/1661-8157\/a003854","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T07:05:17Z","timestamp":1649833517000},"page":"274-282","source":"Crossref","is-referenced-by-count":0,"title":["Verschreibung von nicht-steroidalen Antirheumatika: Analyse von                Abrechnungsdaten der OKP"],"prefix":"10.1024","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0527-4943","authenticated-orcid":false,"given":"Aurelia","family":"Schnyder","sequence":"first","affiliation":[{"name":"Klinik f\u00fcr Nephrologie und                Transplantationsmedizin, Kantonsspital St. Gallen, Schweiz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beat","family":"Br\u00fcngger","sequence":"additional","affiliation":[{"name":"Gesundheitswissenschaften Helsana Gruppe,                Z\u00fcrich, Schweiz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Blozik","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Hausarztmedizin,                Universit\u00e4t Z\u00fcrich, Z\u00fcrich, Schweiz"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"101","reference":[{"key":"c1","unstructured":"ABIM Foundation.  Choosing Wisely . http:\/\/choosingwisely.org; letzter Zugriff:                   04.06.2021."},{"key":"c2","doi-asserted-by":"crossref","unstructured":"Williams AW  , et al., on behalf of the American\n                  Society of Nephrology Quality, and Patient Safety Task Force. Critical and Honest\n                  Conversations: The Evidence Behind the \"Choosing Wisely\" Campaign. Recommendations\n                  by the American Society of Nephrology.  Clin J Am Soc Nephrol . 2012.","DOI":"10.2215\/CJN.04970512"},{"key":"c3","unstructured":"Schweizerische Gesellschaft f\u00fcr Nephrologie. https:\/\/www.swissnephrology.ch\/publications\/; letzter Zugriff\n                  29.01.2022."},{"key":"c4","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2014.09.001"},{"key":"c5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03520100043031"},{"key":"c6","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.12.005"},{"key":"c7","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.101"},{"key":"c8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-1030"},{"key":"c9","first-page":"31","volume":"107","author":"Holt S","year":"2010","journal-title":"Dtsch Artzebl Int"},{"key":"c10","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-013-0073-0"},{"key":"c11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31561-0"},{"key":"c12","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.5441"},{"key":"c13","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2015.05.021"}],"container-title":["Praxis"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/econtent.hogrefe.com\/doi\/pdf\/10.1024\/1661-8157\/a003854","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T10:19:17Z","timestamp":1661941157000},"score":1,"resource":{"primary":{"URL":"https:\/\/econtent.hogrefe.com\/doi\/10.1024\/1661-8157\/a003854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1024\/1661-8157\/a003854"],"URL":"https:\/\/doi.org\/10.1024\/1661-8157\/a003854","relation":{},"ISSN":["1661-8157","1661-8165"],"issn-type":[{"type":"print","value":"1661-8157"},{"type":"electronic","value":"1661-8165"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}